The BET-Bromodomain Inhibitor JQ1 Reduces Inflammation and Tau Phosphorylation at Ser396 in the Brain of the 3xTg Model of Alzheimer’s Disease

Alzheimer’s disease (AD) is a progressive neurodegenerative disease characterized by well-defined neuropathological brain changes including amyloid plaques, neurofibrillary tangles and the presence of chronic neuroinflammation. Objective: The brain penetrant BET bromodomain inhibitor JQ1 has been sh...

Descripción completa

Detalles Bibliográficos
Autores principales: Magistri, Marco, Velmeshev, Dmitry, Makhmutova, Madina, Patel, Prutha, Sartor, Gregory C., Volmar, Claude-Henry, Wahlestedt, Claes, Faghihi, Mohammad Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5026248/
https://www.ncbi.nlm.nih.gov/pubmed/27117003
http://dx.doi.org/10.2174/1567205013666160427101832

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5026248/
https://www.ncbi.nlm.nih.gov/pubmed/27117003
http://dx.doi.org/10.2174/1567205013666160427101832

Ejemplares similares